Company / Working Capital per Share
NovaBay Pharmaceuticals, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.19
FY2024
5-year range
-$0.19 / $3.48
FY2020-FY2024
Trend
-172.6%
vs FY2023
Sector context
#209 of 212
Health Care
What the data says
Among 212 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 1% for working capital per share. Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.19 in FY2024 to $3.48 in FY2022.
Based on SEC 10-K filings.
-0.19 in FY2024.
Declined from $3.48 to $-0.19 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 212This company -$0.19 Sector average $117.56
▼
-100.2% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 172.6% year-over-year.
- Ranks #209 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.19 | -172.6% |
| FY2023 | $0.26 | -92.6% |
| FY2022 | $3.48 | +1460.2% |
| FY2021 | $0.22 | -31.5% |
| FY2020 | $0.33 | +90.6% |
| FY2019 | $0.17 | -38.8% |
| FY2018 | $0.28 | +6.1% |
| FY2017 | $0.26 | -91.0% |
| FY2016 | $2.91 | +5773.8% |
| FY2015 | -$0.05 | -163.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026